ovarian cancer - search results

Researchers at Harvard Medical School and National Cheng Kung University in Taiwan have developed a new artificial intelligence (AI) tool that examine tumor sample images to provide doctors with prognoses and guidance on the most appropriate treatments for colorectal cancer.

Despite today’s detection technology, however, many cancers still go undetected until after the disease has spread. Instead of detecting cancers one by one, various technologies promise multi-cancer early detection (MCED), and some of these approaches are already being used.

George Alexandrakis, a University of Texas at Arlington bioengineering professor, is developing a way of using even very small samples of tissue or blood to find peptide-presenting major histocompatibility complex (MHC) antigens, that indicate which T cell receptor-like antibodies (TCRmAbs) could be used to improve a particular patient’s response to immunotherapies. His goal is to provide a way for doctors to deliver highly personalized cancer care.

Nine germline pathogenic variants, combined with H. pylori infection, raise gastric cancer risk considerably. Several are involved in homologous-recombination.

Mercy BioAnalytics, a developer of an early cancer detection liquid biopsy leveraging extracellular vesicles, has closed a $41 million Series A financing round that will be used to further the development of the company’s novel Mercy Halo test for high-risk lung cancer screening.

Key biologic features of tumor progression are influenced by the circadian rhythm, which could be used to optimize timing of drug delivery and maximize safety and efficacy.

New research links the X-chromosome gene DMD, mutations in which cause Duchenne muscular dystrophy, to a range of different cancers.

New data suggests specific germline-somatic associations can affect cancer development.

Looking beyond genes alone as the drivers of this collection of diseases promises to improve treatment and might one day lead to prevention.

A new study led by researchers from Imperial College London suggests that higher consumption of ultra-processed foods may be linked to increased risks of developing and dying from cancer.